Answers are grounded in this paper and cite their sources.
The ratio of platelets: HDL-C is significantly increased in patients with nascent MetS and appear to be a valid biomarker of MetS. It could also emerge as a biomarker for athero-thrombotic risk. However, these preliminary findings need confirmation in large prospective studies.
No takes yet. Share an insight, caveat, or question.
Jialal et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: